J2KBIO Co., Ltd. (KOSDAQ:420570)
South Korea · Delayed Price · Currency is KRW 8,490.00
+10.00 (0.12%)
At close: Jan 29, 2026
J2KBIO Market Cap
J2KBIO has a market cap or net worth of 48.83 billion as of January 30, 2026. Its market cap has decreased by -7.72% in one year.
Market Cap
48.83B
Enterprise Value
38.61B
Revenue
31.12B
Ranking
n/a
PE Ratio
21.56
Stock Price
8,490.00
Market Cap Chart
Since March 25, 2024, J2KBIO's market cap has decreased from 144.93B to 48.83B, a decrease of -66.31%. That is a compound annual growth rate of -44.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 49.65B | -1.28% |
| Dec 30, 2025 | 50.29B | -3.28% |
| Dec 30, 2024 | 52.00B | -64.12% |
| Mar 25, 2024 | 144.93B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HLB Pep | 78.06B |
| PanGen Biotech | 74.22B |
| MOA Life Plus | 69.70B |
| Ark Solutions | 68.91B |
| EyeGene | 68.48B |
| SunBio,Inc. | 67.92B |
| Aptamer Sciences | 48.91B |
| NGeneBio | 42.56B |